Skip to main content

Transdermal Skin Patches Market will generate new growth opportunities 2023-2028

 


Transdermal patches are a method of drug delivery in which an adhesive patch provides a pre-prescribed dose of medication that is absorbed through the skin and into the bloodstream. The term ‘transdermal’ describes a delivery method used for administering pharmaceuticals. These patches are designed for short-term or long-term administration and can either be electronic or mechanical. Transdermal patches adhere to the skin as a way to deliver drugs. They provide a specific, predetermined dose of medicine which is absorbed through the skin and into the blood. Although comparable to oral-dosage forms in efficacy, skin patches have several advantages over oral forms. They provide a non-invasive and painless method of drug delivery.

Market Statistics:

The global transdermal skin patches market was valued at US$ 7,695.0 Mn in 2021 and is forecast to reach a value of US$ 10,839.7 Mn by 2028 at a CAGR of 5.0% between 2022 and 2028.

Market Drivers:

1.      Growing adoption of transdermal skin patches is expected to boost the growth of the global transdermal skin patches market during the forecast period. For instance, in December 2020, Agile Therapeutics, Inc. announced the U.S. commercial launch of Twirla (levonorgestrel and ethinyl estradiol) transdermal system, a new non-daily, non-invasive contraceptive patch. It is now available in the U.S. by prescription for women of reproductive potential with a BMI 30 kg/m2. It is designed to be worn on the abdomen, buttock, or upper torso (excluding breasts).

2.      Growing funding and investments for drug development is expected to propel the growth of the global transdermal skin patches market over the forecast period. For instance, in May 2019, Mercia invested £2.0 million in transdermal drug delivery specialist Medherant Limited. This latest investment will enable Medherant to finalize the selection of three TEPI Patch products to take into clinical development. The development of patch products that will bring significant benefits to patients across the globe.

 

Labels:

Comments

Post a Comment

Popular posts from this blog

The Global Autoclave Equipment Market Continues To Grow Owing To the Rising Demand from Healthcare Sectors for Sterilizing Medical Equipment to Ensure the Safety of the Post-Surgical Period

  Autoclave equipment is the most popular sterilization method in the industry and is used for many applications including the manufacture of food products. It is widely used in the foodservice industry to sterilize and cleanse equipment used in the process of preparing and serving food. The autoclave is the abbreviated form of autolysis which means oxidation. Autoclaves have various parts including an electric motor, a condenser, and a burner. Autoclave equipment includes vials for sealing the autoclave, a glass or plastic container that has been lined with wax or plastic, and the appropriate autoclave equipment accessories such thermometer for measuring the temperature of the autoclave. All modern steam sterilizing equipment & autoclave machines provide a much-refined workflow experience, which makes you reconsider whether or not steam sterilizing is all it can be. A wide range of sterilization methods is used for sterilizing your medical and laboratory specimen so the right ...
Post a Comment
Read more

Biologics Market Increasing Prevalence of Chronic Diseases to Augment Growth of the market

  A  biologic  drug ( biologics ) is a product that is produced from living organisms or contains components of living organisms.  Biologic  drugs are widely used to prevent, diagnose, treat, or cure a variety of diseases, including infectious diseases, autoimmune disorders, chronic kidney disease, and cancer. Market Dynamics In the recent past, several novel biopharmaceutical products were approved by major regulatory bodies and major players in the market have launched various novel and innovative biopharmaceutical products. Rapid approvals and launches of novel products in the market are expected to be major drivers for growth of the biologicsmarket . 
Post a Comment
Read more

Treprostinil Drugs Market - High Prevalence of Pulmonary Arterial Hypertension and R&D of New Formulations of Treprostinil to Augment Growth of market

  Treprostinil is an antihypertensive agent used to treat patients with pulmonary arterial hypertension. It can also be used in the treatment of Degos disease, an extremely rare disorder in which small and medium sized arteries become blocked (occlusive arteriopathy), restricting the flow of blood to affected areas. Market Dynamics High prevalence of pulmonary arterial hypertension is expected to propel growth of the treprostinil drugs market . For instance, according to the study, ‘High Geographic Prevalence of Pulmonary Artery Hypertension: Associations with Ethnicity, Drug Use, and Altitude’, published in February 2020, in the journal Pulmonary Circulation, the overall pulmonary arterial hypertension incidence was 14 cases per million and the annual period prevalence of pulmonary arterial hypertension was 93 cases per million. Decline in new prescriptions for treprostinil-based products is expected to hinder growth of the treprostinil drugs market. For instance, United The...
Post a Comment
Read more